Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

88
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
88
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

130
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
130
Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

166
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
166
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

601
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
601
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

241
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
241
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

199
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
199

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pediatric Population Pharmacokinetic Modeling and Exposure-Response Analysis of Ambrisentan in Pulmonary Arterial Hypertension and Comparison With Adult Data.

Journal of clinical pharmacology·2022
Same author

Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome.

Journal of pharmacokinetics and pharmacodynamics·2020
Same author

Comparative Evaluation of Median Versus Youden Index Dichotomization Methods: Exposure-Response Analysis of Mycophenolic Acid and Acyl-Glucuronide Metabolite.

European journal of drug metabolism and pharmacokinetics·2019
Same author

A population analysis of the DGAT1 inhibitor GSK3008356 and its effect on endogenous and meal-induced triglyceride turnover in healthy subjects.

Fundamental & clinical pharmacology·2019
Same author

A Gallbladder-Based Enterohepatic Circulation Model for Pharmacokinetic Studies.

European journal of drug metabolism and pharmacokinetics·2018
Same author

Mycophenolic Acid and Its Metabolites in Kidney Transplant Recipients: A Semimechanistic Enterohepatic Circulation Model to Improve Estimating Exposure.

Journal of clinical pharmacology·2018

Related Experiment Video

Updated: Dec 18, 2025

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

16.3K

DosePredict: A Shiny Application for Generalized Pharmacokinetics-Based Dose Predictions.

Malek Okour1

  • 1GlaxoSmithKline, Collegeville, Pennsylvania, USA.

Journal of Clinical Pharmacology
|June 17, 2020
PubMed
Summary
This summary is machine-generated.

DosePredict software streamlines drug development by enabling scientists to perform quantitative dose predictions using pharmacokinetic (PK) models. This tool facilitates reproducible analysis and exploration of various dosing scenarios for personalized medicine.

Keywords:
RShinydata analysisdosepharmacokineticpredictionsoftware

More Related Videos

Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications
07:23

Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications

Published on: October 20, 2023

1.8K
Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish
13:34

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish

Published on: April 16, 2019

9.6K

Related Experiment Videos

Last Updated: Dec 18, 2025

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

16.3K
Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications
07:23

Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications

Published on: October 20, 2023

1.8K
Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish
13:34

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish

Published on: April 16, 2019

9.6K

Area of Science:

  • Pharmacokinetics and Drug Development
  • Computational Biology and Bioinformatics
  • Quantitative Data Analysis in Pharmacology

Background:

  • Dose prediction is crucial in drug development, requiring iterative refinement with emerging data.
  • Current methods involve complex modeling and simulation analyses of preclinical and clinical data.
  • There is a need for efficient and reproducible tools to support dose prediction workflows.

Purpose of the Study:

  • To introduce DosePredict, a novel Shiny-based graphical user interface (GUI) software for dose prediction.
  • To provide a user-friendly platform for pharmacokinetic (PK) modeling and simulation in drug development.
  • To enhance the efficiency and reproducibility of dose prediction analyses.

Main Methods:

  • DosePredict utilizes 1-, 2-, and 3-compartment pharmacokinetic (PK) models.
  • Users input PK model parameters and scenario-specific variables.
  • The software performs stochastic simulations and generates detailed PK and dose prediction outputs.
  • An HTML report is generated, capturing all inputs, outputs, plots, and tables.

Main Results:

  • DosePredict successfully conducts dose predictions based on user-defined PK models and parameters.
  • The software generates comprehensive PK and dose prediction outputs, including visualizations.
  • An integrated HTML reporting feature ensures reproducibility and clear documentation of analyses.
  • Deployment via Shiny server allows for accessible use by scientists.

Conclusions:

  • DosePredict offers a significant advancement in dose prediction tools for drug discovery and development.
  • The software expedites complex analyses, allowing for timely exploration of diverse dosing scenarios.
  • DosePredict supports the development of individualized therapeutic solutions through comprehensive and reproducible dose prediction.